A Study of LY3875383 in Healthy Participants and Participants With Hypertriglyceridemia

Clinical trial NCT05609825 · TERMINATED

Trial details

NCT number: NCT05609825
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypertriglyceridemia

Start date: 2022-11-14
Primary completion: 2024-01-10
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.